# Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block

> **NCT02412657** · NA · COMPLETED · sponsor: **Maisonneuve-Rosemont Hospital** · enrollment: 75 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT02412657
- **Lead sponsor:** Maisonneuve-Rosemont Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412657, "Intravenous Dexamethasone to Increase the Analgesic Duration of Interscalene Block". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02412657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*